At a Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm, Sweden, on the 14th September 2015, Prof Stephen Nicholls of the South Australian Health & Medical Research Institute and University of Adelaide, Adelaide, Australia, describes the control of dysglycaemia in acute coronary syndrome patients and the importance of risk factors other than blood glucose in cardiovascular disease.
From the cardiologist’s perspective, the benefits of intensive glucose lowering alone are uncertain, but increasing evidence supports intensive modification of multiple risk factors to reduce cardiovascular risk in patients with Type 2 diabetes.
